The FDA has approved IV ocrelizumab for treatment of relapsing-remitting MS in children and adolescents aged 10 years and ...

The FDA has approved zenocutuzumab-zbco as the first drug for certain patients with a rare and aggressive bile duct cancer.

Glaucoma and hypertension were both linked with worsened cognitive performance, according to a poster presentation at the ...

In the operating room, the “5-second rule” apparently does not apply.Researchers at Duke University Medical Center ...

Myopia progressed more slowly across 2 years in children wearing Acuvue Abiliti 1-Day daily disposable contact lenses, ...

Published results showed patients who received a higher number of corticosteroid injections before total shoulder ...

The National Kidney Foundation Spring Clinical Meetings opened with presentations on the latest innovations and wins in the ...

Mentoring from other patients may contribute to faster recovery time for patients undergoing hemodialysis, according to study ...

For patients with newly diagnosed atrial fibrillation, a quality improvement initiative improved access to specialist care ...

With several new therapies, extensive research and critical trials underway, nephrology is in a “golden age,” according to ...

Endocrine therapy is one of the top predictors of sexual dysfunction in women cancer survivors, according to a study shown at ...

Extreme heat, air pollution, obesity and Black race are likely independent environmental and social predictors of developing ...